TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
ACET

Adicet Bio Inc

Healthcare · Biotechnology

6.80$ +7.6% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow ACET
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
5.1% 4.9% 1.5% -2.1% -222.2% -2,802.2% -232.1% -524.7% -179.1% – – –
1.4% 1.6% 2.2% 0.0% 14.9% 124.4% 6.8% 15.8% 10.3% – – –
0.4% 0.6% 0.8% 0.1% 30.3% 118.1% 29.4% 128.6% 68.5% – – –
2.0% 5.8% 5.0% 0.8% -98.3% 34.3% -75.5% -62.3% 11.0% – – –
0.2% 0.2% 0.1% 0.0% 10.7% 107.5% 5.5% 134.1% 67.2% – – –
-0.6% -16.8% -1.6% 0.0% -196.3% -4,817.2% 643.6% -28.7% -67.2% – – –
1.2% 1.3% 1.3% 1.3% – – – – – – – –
-8.6% -6.7% -12.2% -10.0% – – – – -12.9% – – –
-2.9% 13.8% -1.5% 11.6% 135.0% 7,733.2% 1.7% 2,494.2% 166.1% – – –
1.7% 1.9% -1.6% 5.5% -283.5% 113.8% 413.2% 1,940.8% -80.2% – – –
4.9% 4.7% 1.4% -2.1% -232.9% -2,909.7% -237.6% -658.8% -246.3% – – –

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?